ACR 0.00% 5.4¢ acrux limited

Ann: Launch of Dapsone 5%, Gel in the United States, page-19

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,036 Posts.
    lightbulb Created with Sketch. 50
    We currently have 3 ANDA's awaiting approval from the FDA. The first mention of Dapsone 7.5% that I have found was 23rd Nov 2022 that this ANDA was currently awaiting approval. I could not find a mention of this ANDA being before the FDA, before that date. Acyclovir Cream mentioned 8/8/22 and Nitroglycerin Ointment 4% 4/7/23. Dapsone has now spent some 16-17 months with the FDA. Hopefully within 6 months this can be launch. On the 27th of May 2022, ACR announced that it had a successful patent ligation and that ACR will be able to launch Aczone (Dapsone) Gel 7.5% once it has FDA approval. Jet
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.